Cellular microparticles and pathophysiology of traumatic brain injury.

Cellular microparticles and pathophysiology of traumatic brain injury.
复制标题

细胞微粒与创伤性脑损伤的病理生理学

DOI:
10.1007/s13238-017-0414-6
复制
发表时间:
2017-11
期刊:
影响因子:
21.1
通讯作者:
Zhang J
Zhang J
中科院分区:
生物学1区
文献类型:
--
作者:
Zhao Z;Zhou Y;Tian Y;Li M;Dong JF;Zhang J

文献摘要

参考文献

被引文献

相似文献

创伤性脑损伤(TBI)是世界范围内死亡和残疾的主要原因。由损伤细胞产生的细胞微粒(MP)对TBI的病理过程产生深刻影响的发现为新的诊断和治疗策略铺平了道路。MP是亚细胞片段或细胞器,其充当亲本细胞特有的脂质、粘附受体、细胞因子、核酸和组织降解酶的载体。它们的亚微米尺寸允许MP前往亲本细胞无法到达的区域,以行使各种生物功能。在这篇综述中,我们总结了最近的事态发展,在确定一个偶然的作用,MP在TBI的病理,并建议MP作为一类新的治疗靶点,用于预防和治疗TBI和相关的全身并发症。
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. The finding that cellular microparticles (MPs) generated by injured cells profoundly impact on pathological courses of TBI has paved the way for new diagnostic and therapeutic strategies. MPs are subcellular fragments or organelles that serve as carriers of lipids, adhesive receptors, cytokines, nucleic acids, and tissue-degrading enzymes that are unique to the parental cells. Their sub-micron sizes allow MPs to travel to areas that parental cells are unable to reach to exercise diverse biological functions. In this review, we summarize recent developments in identifying a casual role of MPs in the pathologies of TBI and suggest that MPs serve as a new class of therapeutic targets for the prevention and treatment of TBI and associated systemic complications.
DOI: 10.3402/jev.v3.24722
发表时间: 2014
影响因子: 16
作者:
Chivet M;Javalet C;Laulagnier K;Blot B;Hemming FJ;Sadoul R
通讯作者: Sadoul R
DOI: 10.1016/s0005-2736(96)00240-4
发表时间: 1997-04-03
影响因子: 3.4
作者:
deKroon, AIPM;Dolis, D;deKruijff, B
通讯作者: deKruijff, B
DOI: 10.1097/htr.0000000000000012
发表时间: 2015-03-01
影响因子: 2.4
作者:
Cuthbert, Jeffrey P.;Harrison-Felix, Cynthia;Whiteneck, Gale G.
通讯作者: Whiteneck, Gale G.
DOI: 10.1038/cddis.2014.511
发表时间: 2014-11-27
影响因子: 9
作者:
通讯作者: --
DOI: 10.3389/fncel.2016.00043
发表时间: 2016
影响因子: 5.3
作者:
Andrews AM;Lutton EM;Merkel SF;Razmpour R;Ramirez SH
通讯作者: Ramirez SH